119 related articles for article (PubMed ID: 16582912)
1. A unique function for cyclin D3 in early B cell development.
Cooper AB; Sawai CM; Sicinska E; Powers SE; Sicinski P; Clark MR; Aifantis I
Nat Immunol; 2006 May; 7(5):489-97. PubMed ID: 16582912
[TBL] [Abstract][Full Text] [Related]
2. Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma.
Pirkmaier A; Dow R; Ganiatsas S; Waring P; Warren K; Thompson A; Hendley J; Germain D
Oncogene; 2003 Jul; 22(28):4425-33. PubMed ID: 12853979
[TBL] [Abstract][Full Text] [Related]
3. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling.
van Loo PF; Dingjan GM; Maas A; Hendriks RW
Immunity; 2007 Sep; 27(3):468-80. PubMed ID: 17869135
[TBL] [Abstract][Full Text] [Related]
4. Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma.
Sasaki E; Yatabe Y; Hashimoto M; Yamashita Y; Hasegawa Y; Kojima H; Nagasawa T; Mori N
Pathol Int; 2007 Feb; 57(2):53-9. PubMed ID: 17300668
[TBL] [Abstract][Full Text] [Related]
5. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
Yu Q; Ciemerych MA; Sicinski P
Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
[TBL] [Abstract][Full Text] [Related]
6. Crucial roles of D-type cyclins in the early stage of adipocyte differentiation.
Hishida T; Naito K; Osada S; Nishizuka M; Imagawa M
Biochem Biophys Res Commun; 2008 May; 370(2):289-94. PubMed ID: 18374658
[TBL] [Abstract][Full Text] [Related]
7. Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation.
Ramazzotti G; Faenza I; Gaboardi GC; Piazzi M; Bavelloni A; Fiume R; Manzoli L; Martelli AM; Cocco L
Cell Signal; 2008 Nov; 20(11):2013-21. PubMed ID: 18694821
[TBL] [Abstract][Full Text] [Related]
8. Requirement for cyclin D3 in germinal center formation and function.
Peled JU; Yu JJ; Venkatesh J; Bi E; Ding BB; Krupski-Downs M; Shaknovich R; Sicinski P; Diamond B; Scharff MD; Ye BH
Cell Res; 2010 Jun; 20(6):631-46. PubMed ID: 20404856
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis.
Rojas P; Cadenas MB; Lin PC; Benavides F; Conti CJ; Rodriguez-Puebla ML
Oncogene; 2007 Mar; 26(12):1723-30. PubMed ID: 16983339
[TBL] [Abstract][Full Text] [Related]
10. Regulation of immunoglobulin light-chain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling.
Johnson K; Hashimshony T; Sawai CM; Pongubala JM; Skok JA; Aifantis I; Singh H
Immunity; 2008 Mar; 28(3):335-45. PubMed ID: 18280186
[TBL] [Abstract][Full Text] [Related]
11. Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development.
Mandal M; Powers SE; Ochiai K; Georgopoulos K; Kee BL; Singh H; Clark MR
Nat Immunol; 2009 Oct; 10(10):1110-7. PubMed ID: 19734904
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclin D3 through Sp1 sites by histone deacetylase inhibitors is mediated with protein kinase C-delta (PKC-delta) signal pathway.
Kim YH; Lim JH; Lee TJ; Park JW; Kwon TK
J Cell Biochem; 2007 Jul; 101(4):987-95. PubMed ID: 17407153
[TBL] [Abstract][Full Text] [Related]
13. Cdk9/Cyclin T1 complex: a key player during the activation/differentiation process of normal lymphoid B cells.
De Falco G; Leucci E; Onnis A; Bellan C; Tigli C; Wirths S; Cerino G; Cocco M; Crupi D; De Luca A; Lanzavecchia A; Tosi P; Leoncini L; Giordano A
J Cell Physiol; 2008 Apr; 215(1):276-82. PubMed ID: 18205180
[TBL] [Abstract][Full Text] [Related]
14. Only VpreB1, but not VpreB2, is expressed at levels which allow normal development of B cells.
Mundt C; Licence S; Maxwell G; Melchers F; Mårtensson IL
Int Immunol; 2006 Jan; 18(1):163-72. PubMed ID: 16361315
[TBL] [Abstract][Full Text] [Related]
15. CD38 cross-linking enhances TLR-induced B cell proliferation but decreases IgM plasma cell differentiation.
Manjarrez-Orduño N; Moreno-García ME; Fink K; Santos-Argumedo L
Eur J Immunol; 2007 Feb; 37(2):358-67. PubMed ID: 17274001
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase 5 represses the transcription of cyclin D3.
Roy S; Shor AC; Bagui TK; Seto E; Pledger WJ
J Cell Biochem; 2008 Aug; 104(6):2143-54. PubMed ID: 18404677
[TBL] [Abstract][Full Text] [Related]
17. Identification of cyclin D3 as a new interaction partner of lamin A/C.
Mariappan I; Gurung R; Thanumalayan S; Parnaik VK
Biochem Biophys Res Commun; 2007 Apr; 355(4):981-5. PubMed ID: 17321498
[TBL] [Abstract][Full Text] [Related]
18. E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivo.
Ebelt H; Zhang Y; Kampke A; Xu J; Schlitt A; Buerke M; Müller-Werdan U; Werdan K; Braun T
Cardiovasc Res; 2008 Nov; 80(2):219-26. PubMed ID: 18628254
[TBL] [Abstract][Full Text] [Related]
19. Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas.
Büschges R; Weber RG; Actor B; Lichter P; Collins VP; Reifenberger G
Brain Pathol; 1999 Jul; 9(3):435-42; discussion 432-3. PubMed ID: 10416984
[TBL] [Abstract][Full Text] [Related]
20. IL-21: an executor of B cell fate.
Konforte D; Simard N; Paige CJ
J Immunol; 2009 Feb; 182(4):1781-7. PubMed ID: 19201828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
